Detalles de la búsqueda
1.
HRD Testing of Ovarian Cancer in Routine Practice: What Are We Dealing With?
Int J Mol Sci
; 24(13)2023 Jun 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37445679
2.
Phase 3, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer: ENGOT-en9/LEAP-001.
Int J Gynecol Cancer
; 32(1): 93-100, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34799418
3.
Alofanib, an allosteric FGFR2 inhibitor, has potent effects on ovarian cancer growth in preclinical studies.
Invest New Drugs
; 35(2): 127-133, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27812884
4.
Optimizing treatment selection and sequencing decisions for first-line maintenance therapy of newly diagnosed advanced ovarian cancer.
Gynecol Oncol Rep
; 42: 101028, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35813356
5.
Detection of NTRK fusions in glioblastoma: fluorescent in situ hybridisation is more useful than pan-TRK immunohistochemistry as a screening tool prior to RNA sequencing.
Pathology
; 54(1): 55-62, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34518039
6.
Breast cancer tumor heterogeneity has only little impact on the estimation of the Oncotype DX® recurrence score using Magee Equations and Magee Decision Algorithm™.
Hum Pathol
; 108: 51-59, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33245987
7.
Surgery in Metastatic Seminoma: Negative Trial Should Be Treated as Negative.
J Clin Oncol
; 41(33): 5202-5203, 2023 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37677119
8.
Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO).
ESMO Open
; 1(6): e000107, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-28255451
Resultados
1 -
8
de 8
1
Próxima >
>>